4acp
From Proteopedia
(Difference between revisions)
m (Protected "4acp" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | + | [[Image:4acp.jpg|left|200px]] | |
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_4acp", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_4acp| PDB=4acp | SCENE= }} | ||
- | + | ===Deactivation of human IgG1 Fc by endoglycosidase treatment=== | |
- | + | ||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_22484364}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 22484364 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_22484364}} | ||
+ | |||
+ | ==About this Structure== | ||
+ | [[4acp]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ACP OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:022484364</ref><references group="xtra"/> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Bowden, T A.]] | ||
+ | [[Category: Crispin, M.]] | ||
+ | [[Category: Dwek, R A.]] | ||
+ | [[Category: Krishna, B A.]] | ||
+ | [[Category: Raman, K.]] | ||
+ | [[Category: Scanlan, C N.]] | ||
+ | [[Category: Antibody]] | ||
+ | [[Category: Igg]] | ||
+ | [[Category: Immune system]] | ||
+ | [[Category: Kifunensine]] |
Revision as of 09:14, 25 April 2012
Deactivation of human IgG1 Fc by endoglycosidase treatment
Template:ABSTRACT PUBMED 22484364
About this Structure
4acp is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Baruah K, Bowden TA, Krishna BA, Dwek RA, Crispin M, Scanlan CN. Selective Deactivation of Serum IgG: A General Strategy for the Enhancement of Monoclonal Antibody Receptor Interactions. J Mol Biol. 2012 Apr 5. PMID:22484364 doi:10.1016/j.jmb.2012.04.002
Categories: Homo sapiens | Bowden, T A. | Crispin, M. | Dwek, R A. | Krishna, B A. | Raman, K. | Scanlan, C N. | Antibody | Igg | Immune system | Kifunensine